Effect of hyperbaric oxygen treatment in central retinal artery occlusion

2018 ◽  
pp. 421-425 ◽  
Author(s):  
Bekir Selim Bağlı ◽  
Sadık Görkem Çevik ◽  
Mediha Tok Çevik ◽  
◽  
◽  
...  
Keyword(s):  
Hyperbaric Oxygen ◽  
Central Retinal Artery Occlusion ◽  
Retinal Artery Occlusion ◽  
Artery Occlusion ◽  
Central Retinal Artery ◽  
Hyperbaric Oxygen Treatment ◽  
Oxygen Treatment ◽  
Retinal Artery

scholarly journals Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen

2016 ◽  
Vol Volume 11 ◽  
pp. 115-125 ◽  
Author(s):  
Amir Hadanny ◽  
Amit Maliar ◽  
Gregory Fishlev ◽  
Yair Bechor ◽  
Jacob Bergan ◽  
...  
Keyword(s):  
Hyperbaric Oxygen ◽  
Central Retinal Artery Occlusion ◽  
Retinal Artery Occlusion ◽  
Retinal Ischemia ◽  
Artery Occlusion ◽  
Central Retinal Artery ◽  
Retinal Artery

The effect of adjunctive hyperbaric oxygen therapy in patients with central retinal artery occlusion

2020 ◽  
pp. 57-64
Author(s):  
Yoon-Seop Kim ◽  
◽  
Myung-Sik Nam ◽  
Eung Joo Park ◽  
Yoonsuk Lee ◽  
...  
Keyword(s):  
Hyperbaric Oxygen ◽  
Central Retinal Artery Occlusion ◽  
Retinal Artery Occlusion ◽  
Artery Occlusion ◽  
Central Retinal Artery ◽  
Medical Society ◽  
Corrected Visual Acuity ◽  
Visual Improvement ◽  
Cilioretinal Artery ◽  
Retinal Artery

Purpose: Central retinal artery occlusion (CRAO) is an ophthalmic emergency with poor prognosis, despite diligent conventional treatment. According to the clinical recommendations of the Undersea and Hyperbaric Medical Society hyperbaric oxygen (HBO2) is a potentially beneficial treatment; however, the benefit of adjunctive HBO2 in patients with CRAO in Korea remains unclear. The present study aimed to evaluate the effect of adjunctive HBO2 in patients with CRAO. Methods: This registry-based observational study included adult patients who presented to the emergency department or ophthalmology outpatient department within 24 hours of the onset of CRAO symptoms. Data of patients from October 2016 to February 2019 were analyzed. The patients were categorized into two groups according to the use of adjunctive HBO2: no HBO2 and HBO2. Result: During the study period, 34 consecutive patients were enrolled, of which 19 were included in the study. In the total cohort, 10 patients (52.6%) were treated with adjunctive HBO2. There were no statistically significant differences in terms of age, sex, comorbidities, duration from symptoms onset to hospital visit, presence of the cilioretinal artery, and use of anterior chamber paracentesis between the two groups. The HBO2 group showed significantly higher change in best-corrected visual acuity than the no-HBO2 group (p=0.043). Conclusion: Patients with CRAO in the HBO2 group showed significantly greater visual improvement than those in the no HBO2 group. Clinicians should consider adjunctive HBO2 in the treatment approach in patients with CRAO who visit the hospital within 24 hours of symptoms onset.

Sign in / Sign up

Export Citation Format

Share Document